Lyumjev ® (insulin lispro – aabc) injection

100 units/mL, 200 units/mL

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

LYUMJEV® (insulin lispro-aabc): Commercial Presentations

For Lyumjev, concentrations of 100 and 200 units/mL have been assessed for commercial availability.

US_cFAQ_URI049_COMMERCIAL_PRESENTATIONS
US_cFAQ_URI049_COMMERCIAL_PRESENTATIONS
en-US

Commercial Presentations

The commercial presentations for Lyumjev 100 units/mL are similar to those of IL-100, and the Lyumjev 200 units/mL Pen to mirror the IL-200 Pen (Commercial Presentations of Lyumjev - Dosage Forms and Strengths).1

Commercial Presentations of Lyumjev - Dosage Forms and Strengths1,2

 

Lyumjev 100 Units/mL

Lyumjev 200 Units/mL

10-mL vial

Yes

No

3-mL KwikPen®

Yes

Yes

3-mL Junior KwikPen®

Yes

No

3-mL Tempo Pen® a

Yes

No

3-mL cartridge

Yes

No

Abbreviation: Lyumjev = Lyumjev® (insulin lispro-aabc).

aTempo Pen™ is marketed in United States only.

References

1Data on file, Eli Lilly and Company and/or one of its subsidiaries.

2Lyumjev [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.

Glossary

IL-100 = Humalog® (insulin lispro injection) 100 units/mL

IL-200 = Humalog® (insulin lispro injection) 200 units/mL

Lyumjev = Lyumjev® (insulin lispro-aabc)

Pen = KwikPen®

Date of Last Review: May 29, 2020


Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 7pm EST

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical